| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $780.6M | +12.7% |
| Cost of Revenue | $314.7M | +10.8% |
| Gross Profit | $465.9M | +13.9% |
| R&D Expense | $142.5M | +1.5% |
| SG&A Expense | $160.9M | -1.2% |
| Operating Income | $91.0M | +665.0% |
| Pre-tax Income | $97.7M | +264.9% |
| Income Tax | $13.2M | +79.3% |
| Net Income | $84.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $428.4M | +35.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $72.5M | +16.6% |
| Current Assets | $541.7M | +7.7% |
| Total Assets | $1.64B | +12.2% |
| Current Liabilities | $221.0M | +14.7% |
| Long-term Debt | $1.49B | +0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $282.7M | +20.3% |
| Capital Expenditures | $178.2M | +49.3% |
| Investing Cash Flow | -$94.8M | -123.6% |
| Financing Cash Flow | -$76.4M | +83.7% |
| Free Cash Flow | $104.6M | -9.6% |
| +335.3% |
| EPS (Basic) | $0.92 | +318.2% |
| EPS (Diluted) | $0.89 | +345.0% |
| Total Liabilities |
| $1.84B |
| +3.8% |
| Stockholders' Equity | -$203.0M | +35.3% |